Nexa shares should trade up toward the implied value of the Boliden exchange ratio and subsequent cash tender offer. Monitor for regulatory approvals and the tender offer launch; the spread to the tender price will narrow as Q1 2027 closing approaches. The 64.68% controlling stake transfer is a transformative event that likely unlocks a significant premium for current holders.
Price Chart
Executive Summary
Votorantim S.A. has signed a definitive agreement to sell its controlling stake in Nexa Resources to Boliden AB via a share-for-share exchange. Boliden will receive 0.250 of its own shares for each Nexa share, is expected to hold 64.68% of Nexa post-closing, and will launch a cash tender offer for minority Nexa shares within 30 days of closing. The transaction is expected to close in Q1 2027, subject to shareholder and regulatory approvals, and represents a transformative change of control that creates a clear premium opportunity for Nexa shareholders.
Key Facts
- Votorantim S.A. signed a definitive agreement to sell its controlling stake in Nexa to Boliden AB.
- Exchange ratio: 0.250 Boliden common shares for each Nexa common share.
- Boliden expected to hold 64.68% of Nexa's total shares and voting rights post-closing.
- Boliden will launch a voluntary cash tender offer for all remaining Nexa minority shares within 30 days of closing.
- Transaction expected to close in Q1 2027, subject to Boliden shareholder approval, Nexa shareholder approval of new board, and regulatory approvals.
- Nexa will remain listed on NYSE and continue as a separate legal entity under Luxembourg law.
- Nexa's existing management team is expected to remain in place.
- Goldman Sachs is acting as financial advisor to Nexa.
Financial Impact
Change of control at a premium via share-for-share exchange; minority shareholders will receive a cash tender offer at a price determined by the 0.250 exchange ratio and Boliden's VWAP. The transaction creates a clear premium opportunity for Nexa shareholders.
Risk Factors
- Transaction may not close if required shareholder or regulatory approvals are not obtained.
- The cash tender offer price for minority shares depends on Boliden's future stock price, creating uncertainty.
- Delays in closing beyond Q1 2027 could weigh on the stock.
- Peruvian mandatory tender offers for subsidiaries may introduce additional complexity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001292814-26-004362 |
| Document: 0001292814-26-004362-index-headers.html | 0001292814-26-004362 |
| Document: 0001292814-26-004362-index.html | 0001292814-26-004362 |
| Document: 0001292814-26-004362.txt | 0001292814-26-004362 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | 6-K | $13.90 $12.64 | ▼ −9.06% | ▼ −8.56% | $12.24 (−11.94%) |
Aug 5, 2026 8w ago | 6-K | $14.05 $13.34 | ▼ −5.05% | ▼ −4.45% | $12.24 (−12.88%) |
Jun 25, 2026 14w ago | 6-K | $12.85 $13.22 | ▲ +2.88% | ▲ +1.62% | $12.24 (−4.75%) |
May 29, 2026 18w ago | 6-K | $16.19 $12.24 | ▼ −24.40% | ▼ −23.10% | $12.24 (−24.40%) |
Apr 24, 2026 23w ago | 6-K | $14.43 $14.19 | ▼ −1.66% | ▼ −5.69% | $12.24 (−15.18%) |
Mar 26, 2026 27w ago | 6-K | $10.04 $14.52 | ▲ +44.62% | ▲ +31.88% | $12.24 (+21.91%) |
Mar 26, 2026 27w ago | 6-K | $10.04 $14.52 | ▲ +44.62% | ▲ +31.88% | $12.24 (+21.91%) |
Mar 26, 2026 27w ago | 20-F | $10.04 $14.52 | ▲ +44.62% | ▲ +31.88% | $12.24 (+21.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access